Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 317

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens

Brinster, Sophie, Lamberet, Gilles, Staels, Bart, Trieu-Cuot, Patrick, Gruss, Alexandra, Poyart, Claire·2009·Nature
DOI 10.1038/nature07772
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nature07772

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 30

  1. Altabe, S., Lopez, P. & de Mendoza, D. Isolation and characterization of unsaturated fatty acid auxotrophs of Streptococcus pneumoniae and Streptococcus mutans . J. Bacteriol. 189, 8139–8144 (2007) · DOI
  2. Marrakchi, H., Zhang, Y. M. & Rock, C. O. Mechanistic diversity and regulation of Type II fatty acid synthesis. Biochem. Soc. Trans. 30, 1050–1055 (2002) · DOI
  3. Price, A. C. et al. Inhibition of beta-ketoacyl-acyl carrier protein synthases by thiolactomycin and cerulenin. Structure and mechanism. J. Biol. Chem. 276, 6551–6559 (2001) · DOI · Paper page
  4. Wright, H. T. & Reynolds, K. A. Antibacterial targets in fatty acid biosynthesis. Curr. Opin. Microbiol. 10, 447–453 (2007) · DOI
  5. Zhang, Y. M., White, S. W. & Rock, C. O. Inhibiting bacterial fatty acid synthesis. J. Biol. Chem. 281, 17541–17544 (2006) · DOI · Paper page
  6. Wang, J. et al. Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 441, 358–361 (2006) · DOI · Paper page
  7. Wang, J. et al. Discovery of platencin, a dual FabF and FabH inhibitor with in vivo antibiotic properties. Proc. Natl Acad. Sci. USA 104, 7612–7616 (2007) · DOI · Paper page
  8. Campbell, J. W. & Cronan, J. E. Bacterial fatty acid biosynthesis: targets for antibacterial drug discovery. Annu. Rev. Microbiol. 55, 305–332 (2001) · DOI · Paper page
  9. Johnsson, T., Nikkila, P., Toivonen, L., Rosenqvist, H. & Laakso, S. Cellular fatty acid profiles of Lactobacillus and Lactococcus strains in relation to the oleic acid content of the cultivation medium. Appl. Environ. Microbiol. 61, 4497–4499 (1995) · DOI
  10. Altenbern, R. A. Cerulenin-inhibited cells of Staphylococcus aureus resume growth when supplemented with either a saturated or an unsaturated fatty acid. Antimicrob. Agents Chemother. 11, 574–576 (1977) · DOI
  11. Kankaanpaa, P., Yang, B., Kallio, H., Isolauri, E. & Salminen, S. Effects of polyunsaturated fatty acids in growth medium on lipid composition and on physicochemical surface properties of lactobacilli. Appl. Environ. Microbiol. 70, 129–136 (2004) · DOI
  12. Yamamoto, Y. et al. The group B streptococcus NADH oxidase Nox-2 is involved in fatty acid biosynthesis during aerobic growth and contributes to virulence. Mol. Microbiol. 62, 772–785 (2006) · DOI
  13. Campbell, J. W. & Cronan, J. E. Escherichia coli FadR positively regulates transcription of the fabB fatty acid biosynthetic gene. J. Bacteriol. 183, 5982–5990 (2001) · DOI
  14. Lai, C. Y. & Cronan, J. E. Beta-ketoacyl-acyl carrier protein synthase III (FabH) is essential for bacterial fatty acid synthesis. J. Biol. Chem. 278, 51494–51503 (2003) · DOI
  15. Fozo, E. M. & Quivey, R. G. The fabM gene product of Streptococcus mutans is responsible for the synthesis of monounsaturated fatty acids and is necessary for survival at low pH. J. Bacteriol. 186, 4152–4158 (2004) · DOI
  16. Fozo, E. M., Scott-Anne, K., Koo, H. & Quivey, R. G. Role of unsaturated fatty acid biosynthesis in virulence of Streptococcus mutans . Infect. Immun. 75, 1537–1539 (2007) · DOI
  17. Nakamura, T. et al. Serum fatty acid levels, dietary style and coronary heart disease in three neighbouring areas in Japan: the Kumihama study. Br. J. Nutr. 89, 267–272 (2003) · DOI
  18. Raetz, C. R., Reynolds, C. M., Trent, M. S. & Bishop, R. E. Lipid A modification systems in gram-negative bacteria. Annu. Rev. Biochem. 76, 295–329 (2007) · DOI · Paper page
  19. Bhargava, H. N. & Leonard, P. A. Triclosan: applications and safety. Am. J. Infect. Control 24, 209–218 (1996) · DOI · Paper page
  20. Glaser, P. et al. Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol. Microbiol. 45, 1499–1513 (2002) · DOI · Paper page
  21. Hamilton, J. A. How fatty acids bind to proteins: the inside story from protein structures. Prostaglandins Leukot. Essent. Fatty Acids 67, 65–72 (2002) · DOI
  22. Moellering, R. C. & Weinberg, A. N. Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococci. J. Clin. Invest. 50, 2580–2584 (1971) · DOI · Paper page
  23. Berger, J. & Moller, D. E. The mechanisms of action of PPARs. Annu. Rev. Med. 53, 409–435 (2002) · DOI · Paper page
  24. Staels, B., Maes, M. & Zambon, A. Fibrates and future PPARalpha agonists in the treatment of cardiovascular disease. Nature Clin. Pract. Cardiovasc. Med. 5, 542–553 (2008) · DOI · Paper page
  25. Scortti, M. et al. Coexpression of virulence and fosfomycin susceptibility in Listeria: molecular basis of an antimicrobial in vitro-in vivo paradox. Nature Med. 12, 515–517 (2006) · doi:10.1038/nm1396
  26. Gill, C. J. et al. In vivo activity and pharmacokinetic evaluation of a novel long-acting carbapenem antibiotic, MK-826 (L-749,345). Antimicrob. Agents Chemother. 42, 1996–2001 (1998) · doi:10.1128/aac.42.8.1996
  27. Tomita, Y., Miyake, N. & Yamanaka, S. Lipids in human parotid saliva with regard to caries experience. J. Oleo Sci. 57, 115–121 (2008) · DOI
  28. Yamamoto, Y. et al. Respiration metabolism of group B streptococcus is activated by environmental haem and quinone and contributes to virulence. Mol. Microbiol. 56, 525–534 (2005) · DOI · Paper page
  29. Dramsi, S. et al. Assembly and role of pili in group B streptococci. Mol. Microbiol. 60, 1401–1413 (2006) · DOI · Paper page
  30. Maguin, E., Prevost, H., Ehrlich, S. D. & Gruss, A. Efficient insertional mutagenesis in lactococci and other gram-positive bacteria. J. Bacteriol. 178, 931–935 (1996) · DOI · Paper page

Cited by

See all 317

Metadata

Authors
Brinster, S., Lamberet, G., Staels, B., Trieu-Cuot, P., Gruss, A., & Poyart, C.
Venue
Nature
Publisher
Springer Science and Business Media LLC
Published
2009-03
Volume
458
Issue
7234
Pages
83-86
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
DOI
10.1038/nature07772
OpenAlex
W1987678916
Cited by
317
References
1
FWCI
22.63
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens. https://app.cochat.ai/papers/10.1038/nature07772
The paper
Brinster, S., Lamberet, G., Staels, B., Trieu-Cuot, P., Gruss, A., & Poyart, C. (2009). Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogens. Nature. https://doi.org/10.1038/nature07772

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.